CAMP4 Therapeutics entered a strategic collaboration with GSK to advance RNA-based therapeutic discoveries.
CAMP4 Therapeutics is a clinical-stage biotechnology company harnessing the power of RNA to address genetic diseases characterized by decreased protein expression
CAMP4 Therapeutics is a clinical-stage biotechnology company harnessing the power of RNA to address genetic diseases characterized by decreased protein expression. CAMP4’s RAP Platform® enables the mapping of regulatory RNA (regRNA) sequences that function as master regulators of gene expression and the design of programmable therapeutic ASO candidates targeting these regRNAs.